Achondroplasia is a type of dwarfism that affects the growth in children, leading to a short stature or small size. Achondroplasia is a rare genetic condition that affects one in every 15,000 to ...

Exclusion criteria included a height that was less than 2 SD below the mean or greater than 2 SD above the mean on achondroplasia growth charts ... 11.5), and 58% were female.

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for TransCon ® CNP (navepegritide) for the treatment of children with achondroplasia, a rare ...

The most common cause of DSS is achondroplasia ... growth rate is declining, a pediatrician looks for signs of failure to thrive. The World Health Organization (WHO) developed growth percentile ...

A promising daily tablet is effective at increasing height and improving proportional limb growth in children with ...

"VOXZOGO is now becoming the standard of care in achondroplasia, based on its proven effects on growth velocity, its safety profile and the clinical data demonstrating positive impact on ...

COPENHAGEN, Denmark, May 05, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will share the latest data from its hypoparathyroidism, achondroplasia, and growth ...